Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22252372 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting PET Imaging of the Translocator Proteine Ligands (TSPO) With [18 F] DPA-714 Biomarker of NeuroInflammation in Cognitive Decline (NIDECO)
Conditions: Memory Complaint;   Mild Cognitive Impairment;   Alzheimer Disease
Intervention: Drug: [18F]DPA-714 PET/ [18F]AV-45 PET/neuropsychological assessment

Indicates status has not been verified in more than two years